ZA200903018B - Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis - Google Patents

Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis

Info

Publication number
ZA200903018B
ZA200903018B ZA200903018A ZA200903018A ZA200903018B ZA 200903018 B ZA200903018 B ZA 200903018B ZA 200903018 A ZA200903018 A ZA 200903018A ZA 200903018 A ZA200903018 A ZA 200903018A ZA 200903018 B ZA200903018 B ZA 200903018B
Authority
ZA
South Africa
Prior art keywords
immunosuppression
diagnosis
micro
metastatic melanoma
array analysis
Prior art date
Application number
ZA200903018A
Other languages
English (en)
Inventor
Anna Karolina Palucka
Jacques F Banchereau
Damien Chaussabel
Original Assignee
Baylor Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor Res Inst filed Critical Baylor Res Inst
Publication of ZA200903018B publication Critical patent/ZA200903018B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Data Mining & Analysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200903018A 2006-11-03 2009-04-30 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis ZA200903018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85640606P 2006-11-03 2006-11-03

Publications (1)

Publication Number Publication Date
ZA200903018B true ZA200903018B (en) 2010-03-31

Family

ID=39690661

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200903018A ZA200903018B (en) 2006-11-03 2009-04-30 Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis

Country Status (12)

Country Link
US (1) US20100076691A1 (xx)
EP (4) EP2570951A1 (xx)
JP (1) JP2010508826A (xx)
KR (1) KR20090078365A (xx)
CN (1) CN101601042A (xx)
AU (1) AU2007347118B2 (xx)
CA (1) CA2704288A1 (xx)
HK (1) HK1131833A1 (xx)
IL (1) IL198360A0 (xx)
NZ (3) NZ598954A (xx)
WO (1) WO2008100352A2 (xx)
ZA (1) ZA200903018B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2010021696A1 (en) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
WO2010083121A1 (en) 2009-01-15 2010-07-22 The Board Of Trustees Of The Leland Stanford Junior University Biomarker panel for diagnosis and prediction of graft rejection
EP2507630B1 (en) 2009-12-02 2017-01-25 The Board of Trustees of The Leland Stanford Junior University Biomarkers for determining an allograft tolerant phenotype
US9410205B2 (en) 2010-02-18 2016-08-09 New York University Methods for predicting survival in metastatic melanoma patients
WO2011119980A1 (en) 2010-03-25 2011-09-29 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
TWI539158B (zh) * 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
US20130303400A1 (en) * 2010-11-26 2013-11-14 Robert Zeillinger Multimarker panel
WO2012099872A1 (en) * 2011-01-18 2012-07-26 Everist Genomics, Inc. Prognostic signature for colorectal cancer recurrence
WO2012154935A1 (en) * 2011-05-12 2012-11-15 Eisai R&D Management Co., Ltd. Biomarkers that are predictive of responsiveness or non-responsiveness to treatment with lenvatinib or a pharmaceutically acceptable salt thereof
CN102944539B (zh) * 2012-09-24 2015-02-25 杭州师范大学 基于量子点共振能量转移的mgmt活性检测试剂盒及方法
CA2906523A1 (en) * 2013-03-15 2014-09-25 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
JP6496899B2 (ja) * 2014-07-01 2019-04-10 公立大学法人福島県立医科大学 浸潤性髄膜腫判別用試薬、及びその判別方法
WO2016003810A1 (en) 2014-07-02 2016-01-07 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
CN104774252B (zh) * 2015-04-03 2018-02-06 西南大学 特异调控单宁合成的转录因子PtoMYB115及其用途
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
JP7227964B2 (ja) * 2017-05-25 2023-02-22 リキッド バイオプシー リサーチ リミティド ライアビリティ カンパニー 黒色腫の検出方法
WO2019173283A1 (en) 2018-03-05 2019-09-12 Marquette University Method and apparatus for non-invasive hemoglobin level prediction
AT521641B1 (de) * 2018-09-12 2020-07-15 Fianostics Gmbh Verfahren zur Diagnose von Lebererkrankungen
US20220002815A1 (en) * 2018-11-04 2022-01-06 Pfs Genomics, Inc. Methods and genomic classifiers for prognosis of breast cancer and predicting benefit from adjuvant radiotherapy
KR102247432B1 (ko) 2019-01-21 2021-05-03 주식회사 에스씨엘헬스케어 암 진단용 바이오 마커 조성물 및 이의 용도
IT201900023946A1 (it) * 2019-12-13 2021-06-13 Complexdata S R L Metodo per determinare una prognosi di sopravvivenza a lungo termine di pazienti di cancro al seno, sulla base di algoritmi che modellizzano reti biologiche
CN111487399B (zh) * 2020-03-26 2021-09-17 湖南师范大学 一种蛋白分子标记在鱼类生殖细胞发育研究中的应用
CN113278630B (zh) * 2021-05-26 2022-02-15 安徽农业大学 一种改良桑树白藜芦醇生物合成的转录因子基因MaMYB14及其应用
EP4388136A1 (en) * 2021-08-17 2024-06-26 Biomeme, Inc. Methods for characterizing infections and methods for developing tests for the same

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
ATE293011T1 (de) 1991-11-22 2005-04-15 Affymetrix Inc A Delaware Corp Kombinatorische strategien für die polymersynthese
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
JP2002515738A (ja) 1996-01-23 2002-05-28 アフィメトリックス，インコーポレイティド 核酸分析法
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
US20050222029A1 (en) * 2001-01-04 2005-10-06 Myriad Genetics, Incorporated Compositions and methods for treating diseases
US6955788B2 (en) 2001-09-07 2005-10-18 Affymetrix, Inc. Apparatus and method for aligning microarray printing head
WO2005074540A2 (en) * 2004-01-30 2005-08-18 University Of Pennsylvania Novel predictors of transplant rejection determined by peripheral blood gene-expression profiling

Also Published As

Publication number Publication date
NZ576428A (en) 2012-04-27
EP2080140B1 (en) 2013-04-24
JP2010508826A (ja) 2010-03-25
US20100076691A1 (en) 2010-03-25
EP2570951A1 (en) 2013-03-20
EP2579174A1 (en) 2013-04-10
AU2007347118A1 (en) 2008-08-21
NZ598954A (en) 2012-10-26
HK1131833A1 (en) 2010-02-05
AU2007347118B2 (en) 2012-11-01
KR20090078365A (ko) 2009-07-17
WO2008100352A2 (en) 2008-08-21
NZ588574A (en) 2012-07-27
IL198360A0 (en) 2010-02-17
WO2008100352A3 (en) 2008-12-11
CA2704288A1 (en) 2008-08-21
EP2080140A4 (en) 2011-08-10
EP2506172A1 (en) 2012-10-03
CN101601042A (zh) 2009-12-09
EP2080140A2 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
ZA200903018B (en) Diagnosis of metastatic melanoma and monitoring indicators of immunosuppression through blood leukocyte micro-array analysis
EP1963533A4 (en) ANALYSIS OF THE CONCENTRATION OF PERIPHERAL TRANSCRIPTIONAL PATH MODULES OF BLOOD WHITE GLOBULES
EP2228657A4 (en) MICROCHIP AND BLOOD MONITORING DEVICE
EP1942801A4 (en) ANALYTICAL MONITORING DEVICE AND METHOD OF USE
EP1988824A4 (en) CLINICAL APPLICATIONS OF STO2 ANALYSIS
EP2166928A4 (en) HEALTH MONITOR
HK1129458A1 (en) Assays for diagnosing and evaluating treatment options for fabry disease
PL2064993T3 (pl) Czujnik krwi i przyrząd do badania krwi zawierający ten czujnik
ZA201000095B (en) Multiple analysis of blood samples
EP2182848A4 (en) ANALYTICAL MONITORING DEVICE AND METHOD OF USE
GB0616376D0 (en) Raman analysis of tissue
EP2118654A4 (en) DIAGNOSTIC TEST FOR THE DETECTION OF A MOLECULE OR DRUG IN WHOLE BLOOD
EP3108811C0 (en) SAFE BLOOD COLLECTION ARRANGEMENT WITH INDICATOR
EP2061375A4 (en) DEVICES AND METHODS FOR THE COLLECTION AND ANALYSIS OF ORGANIC LIQUIDS
HK1135886A1 (en) Monitoring system and probe
BRPI0913578A2 (pt) diagnose de melanoma e lentigo solar por análise de ácido nucléico
IL187859A0 (en) Diagnosis and prognosis of diabetes
EP2217138A4 (en) SENSOR UNIT AND METHOD FOR MONITORING INTRAKRANIAL PHYSIOLOGICAL PROPERTIES
EP2153777A4 (en) ULTRASONIC PROBE AND ULTRASONIC DIAGNOSTIC DEVICE
EP1968648A4 (en) DIAGNOSIS SYSTEM FOR THE DETECTION AND DIAGNOSIS OF SKIN CANCER
EP1735115A4 (en) HIGH PRESSURE CLEANER WITH DIAGNOSTIC INDICATIONS
GB2450241B (en) Systems and methods for health monitoring of complex systems
EP2306901A4 (en) ONE-WAY LENS SENSOR ARRANGEMENT AND METER THEREFORE
HK1151709A1 (en) Blood flow measuring apparatus and brain activity measuring apparatus using the same
ZA201102086B (en) Measuring and monitoring mental capacity